FDA OKs Duaklir Fixed-Dose Combination Inhaler for COPD FDA OKs Duaklir Fixed-Dose Combination Inhaler for COPD

Duaklir combines aclidinium bromide and formoterol fumarate and is administered twice daily via a breath-actuated inhaler for maintenance treatment of COPD.FDA Approvals
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Pulmonary Medicine News Alert Source Type: news